Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Net revenue (1) $ 28,000 [1] $ 516,000 [1] $ 62,000 [1] $ 592,000 [1]
Cost of sales 19,000 458,000 40,000 503,000
Gross profit 9,000 58,000 22,000 89,000
Operating expenses:        
Selling and administrative expenses 342,000 687,000 654,000 1,401,000
Amortization of prepaid advisory fees 414,000 423,000 825,000 830,000
Research and development 123,000 236,000 230,000 526,000
Total operating expense 879,000 1,346,000 1,709,000 2,757,000
Operating loss (870,000) (1,288,000) (1,687,000) (2,668,000)
Other income (expense):        
Change in fair value of derivate liabilities 2,000 2,184,000 83,000 3,572,000
Interest expense, net (47,000) (20,000) (100,000) (37,000)
Gain on settlement of accrued liability 0 0 42,000 0
Net (loss) income $ (915,000) $ 876,000 $ (1,662,000) $ 867,000
Net income (loss) per share - basic $ (0.02) $ 0.02 $ (0.03) $ 0.02
Net income (loss) per share - diluted $ (0.02) $ 0.02 $ (0.03) $ 0.02
Weighted average number of common shares outstanding - basic 47,715,793 46,614,250 47,604,706 46,022,798
Weighted average number of common shares outstanding - diluted 47,715,793 50,878,086 47,604,706 50,243,557
[1] Includes sales to related parties for the three and six months ended December 31, 2012, of approximately $11,000 and $31,000, respectively.